Conditions: Carcinoma Renal Cell Non Clear Cell Renal Carcinoma Papillary Cell Renal Carcinoma Adenocarcinoma
Keywords: renal cell carcinoma non clear cell carcinoma papillary cell renal carcinoma adults everolimus
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 92
Healthy volunteers: no

Brief summary:
To evaluate the preliminary efficacy and safety of RAD001 as monotherapy for first-line treatment of patients with metastatic papillary carcinoma of the kidney.

Detailed description:

Arms:
arm 1: two 5 mg tablets of everolimus orally, once daily

Interventions: intervention 1: RAD001
Intervention descriptions: intervention 1: None

Protocol document: